about
Effects of androgen deprivation therapy on telomere length.Biochemical evaluation of male androgen status: Beyond total testosterone.The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment.Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the AustralPhysiological basis behind ergogenic effects of anabolic androgensHypogonadism and male obesity: Focus on unresolved questionsHypocalcaemia following denosumab in prostate cancer: A clinical reviewReproductive Endocrinology of Nonalcoholic Fatty Liver DiseaseLate-onset hypogonadism: metabolic impactTestosterone deficiency in men with Type 2 diabetes: pathophysiology and treatmentBiomechanical leg muscle function during stair ambulation in men receiving androgen deprivation therapyAssessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: position statement summaryAustralian endocrinologists need more training in transgender health: A national surveyReversible male hypogonadotropic hypogonadism due to energy deficitCardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast CancerManagement of bone and metabolic effects of androgen deprivation therapyTestosterone therapy considerations in estrogen, progesterone and androgen receptor positive breast cancer in a transgender maleDiffering effects of zoledronic acid on bone microarchitecture and bone mineral density in men receiving androgen deprivation therapy: a randomised controlled trial
P50
Q48098854-BB40EF16-7331-4700-994A-CCF9ECBFEEEEQ48197972-9D7B99A3-67E4-41AA-A309-24F2910F8CEDQ48352193-44DFF18D-60A2-4A49-8E78-CC12DC8ADE90Q57106724-3AFBCABA-0C5B-4F89-A459-F87177F30399Q62978381-03783A58-EF28-4F76-A199-7FE3E6CF5B11Q88438763-3B6DCD89-3BA8-484A-B86A-BDF81006A613Q89524843-5777C954-4752-42A8-A5A1-236A87C20A8AQ90003047-51412DBC-EB9B-49E9-AF0F-F332DA5C3248Q90014878-587CE0F8-35D0-4C4D-ADF5-B0285D774B9BQ90044475-5DF7FE41-A516-4DF6-970D-9B1644206DA6Q91920180-24A24BF4-440B-499E-A2C4-B16CE716ACF8Q91983461-2D8ABE7E-1CF1-4586-AA9F-3FD388695D26Q92034664-F16C6AE3-0B71-475D-9A5A-B890DF488D9AQ92568195-38C4798E-8706-46AA-A077-33BE89CB4EABQ93152835-62EF76A6-83F7-493C-8B4D-A9549216A4FBQ93182748-25255CE4-40AF-4CC6-8E42-7345CF657813Q96292972-5E2488E6-0D47-4F9A-8FC5-028CB9AD2903Q96433652-DB3AC45A-4A12-4EC5-8D7E-72007439BFED
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mathis Grossmann
@ast
Mathis Grossmann
@en
Mathis Grossmann
@es
Mathis Grossmann
@nl
Mathis Grossmann
@sl
type
label
Mathis Grossmann
@ast
Mathis Grossmann
@en
Mathis Grossmann
@es
Mathis Grossmann
@nl
Mathis Grossmann
@sl
prefLabel
Mathis Grossmann
@ast
Mathis Grossmann
@en
Mathis Grossmann
@es
Mathis Grossmann
@nl
Mathis Grossmann
@sl
P106
P21
P31
P496
0000-0001-8261-3457
P569
2000-01-01T00:00:00Z